Treatment regimens and glycaemic outcomes in more than 100 000 children with type 1 diabetes (2013–22): a longitudinal analysis of data from paediatric diabetes registries,The Lancet Diabetes & Endocrinology

当前位置： X-MOL 学术 › Lancet Diabetes Endocrinol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Treatment regimens and glycaemic outcomes in more than 100 000 children with type 1 diabetes (2013–22): a longitudinal analysis of data from paediatric diabetes registries
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2024-11-29 , DOI: 10.1016/s2213-8587(24)00279-1
Anthony T Zimmermann ₁ , Stefanie Lanzinger ₂ , Siv Janne Kummernes ₃ , Nicolai A Lund-Blix ₃ , Reinhard W Holl ₂ , Elke Fröhlich-Reiterer ₄ , David M Maahs ₅ , Osagie Ebekozien ₆ , Saketh Rompicherla ₇ , Justin T Warner ₈ , Saira Pons Perez ₉ , Holly Robinson ₁₀ , Maria E Craig ₁₁ , Stephanie Johnson ₁₂ , Karin Akesson ₁₃ , Alexander Thorén ₁₄ , Katarina Eeg-Olofsson ₁₅ , Ajenthen G Ranjan ₁₆ , Mette Madsen ₁₇ , Michael Witsch ₁₈ , Heiko Bratke ₁₉ , G Todd Alonso ₂₀ , Zdenek Sumnik ₂₁ , Vit Neuman ₂₁ , Ondrej Cinek ₂₁ , Torild Skrivarhaug ₂₂ , Jannet Svensson ₂₃

Affiliation

Division of Medicine, Lyell McEwin Hospital, Adelaide, SA, Australia.
Institute of Epidemiology and Medical Biometry, Computer Assisted Quality Management, Ulm University, Ulm, Germany; German Center for Diabetes Research, Munich-Neuherberg, Munich, Germany.
The Norwegian Childhood Diabetes Registry, Division of Childhood and Adolescent Medicine, Oslo University Hospital, Oslo, Norway.
Department of Paediatric and Adolescent Medicine, Medical University of Graz, Graz, Austria.
Department of Pediatrics, Division of Endocrinology, Stanford University School of Medicine, California, CA, USA.
T1D Exchange, Boston, MA, USA; School of Medicine, University of Mississippi, Jackson, MI, USA.
T1D Exchange, Boston, MA, USA.
National Paediatric Diabetes Audit, Noah's Ark Children's Hospital for Wales, Cardiff, UK.
National Paediatric Diabetes Audit, Royal College of Paediatrics and Child Health, London, UK.
Royal College of Paediatrics and Child Health, London, UK.
Paediatrics and Child Health, University of New South Wales, Sydney, NSW, Australia; Charles Perkins Centre Westmead, University of Sydney, Sydney, NSW, Australia.
Department of Endocrinology, Queensland Children's Hospital, Brisbane, QLD, Australia.
The Swedish National Diabetes Register, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden; Department of Pediatrics, Ryhov County Hospital, Jönköping, Sweden; The Swedish National Diabetes Register, Center of Registers, Gothenburg, Sweden.
The Swedish National Diabetes Register, Center of Registers, Gothenburg, Sweden.
The Swedish National Diabetes Register, Center of Registers, Gothenburg, Sweden; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
Steno Diabetes Center Copenhagen, Herlev, Denmark.
Steno Diabetes Center North Denmark, Aalborg University Hospital, Aalborg, Denmark; Department of Pediatrics and Adolescent Medicine, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Aalborg University, Gistrup, Denmark.
Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.
Department of Pediatrics, Haugesund Hospital, Fonna Health Trust, Haugesund, Norway.
Barbara Davis Center, University of Colorado, Aurora, CO, USA.
Department of Pediatrics, 2nd Faculty of Medicine, Motol University Hospital, Charles University, Prague, Czechia.
The Norwegian Childhood Diabetes Registry, Division of Childhood and Adolescent Medicine, Oslo University Hospital, Oslo, Norway; Oslo Diabetes Research Center, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden; Steno Diabetes Center Copenhagen, Herlev, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Advances in paediatric type 1 diabetes management and increased use of diabetes technology have led to improvements in glycaemia, reduced risk of severe hypoglycaemia, and improved quality of life. Since 1993, progressively lower HbA1c targets have been set. The aim of this study was to perform a longitudinal analysis of HbA1c, treatment regimens, and acute complications between 2013 and 2022 using data from eight national and one international paediatric diabetes registries.

中文翻译：

超过 100 000 名 1 型糖尿病儿童的治疗方案和血糖结果（2013-22）：儿科糖尿病登记处数据的纵向分析

儿科 1 型糖尿病管理的进步和糖尿病技术使用的增加导致血糖改善、严重低血糖风险降低和生活质量改善。自 1993 年以来，已设定逐渐降低 HbA1c 的目标。本研究的目的是使用来自 8 个国家和 1 个国际儿科糖尿病登记处的数据，对 2013 年至 2022 年间的 HbA1c、治疗方案和急性并发症进行纵向分析。

更新日期：2024-11-29

点击分享查看原文

点击收藏

阅读更多本刊新发论文